Show results for
Refine by
Cancer Center Case Study Equipment & Supplies In Finland
219 equipment items found
Manufactured by:Cartherics Pty ltd based inNotting Hill, AUSTRALIA
Indication: Ovarian Cancer. Research: iNK cells [TAG-72 CAR + gene ...
Manufactured by:phasetwo based inAlpharetta, GEORGIA (US) (USA)
The Dewar Series from phasetwo introduces advanced technology in traditional-sized models ranging from 25 to 50 liters, incorporating a Liquid Withdrawal Device (LWD) engineered for ease of use with a secure half-turn attachment feature. The design integrates premium multi-layer insulation complemented by state-of-the-art vacuum technology, achieving peak industry performance in liquid ...
Manufactured by:The Menarini Group based inFlorence, ITALY
Elacestrant is a selective estrogen receptor degrader (SERD) evaluated for potential use as a once daily oral treatment in patients with estrogen receptor positive (ER+)/HER2- advanced or metastatic breast cancer. Studies completed to date, including the positive results from the EMERALD phase 3 trial, indicate that the compound has the potential for use as a single agent or in combination with ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor activity in several ...
Manufactured by:Xstrahl based inNorcross, GEORGIA (US) (USA)
The SARRP FLASH system by Xstrahl exemplifies cutting-edge technology in preclinical radiation therapy. This system leverages the advanced FLASH-RT technique, which administers ultra-high dose rates of radiation, significantly surpassing conventional methods. This approach aims to effectively target tumors while minimizing damage to surrounding healthy tissues, making it pivotal for translational ...
by:Huabio based inWoburn, MASSACHUSETTS (USA)
Western blot analysis of HIF-1 beta on human liver tissue lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (ET1609-67, 1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room ...
Manufactured by:Precision X-Ray based inMadison, CONNECTICUT (USA)
Precision X-Ray's X-Rad320 is a state-of-the-art X-ray irradiation system designed to offer precise radiation doses to a wide range of specimens, from cells to small animals. The system includes an OptiMAX imaging module that facilitates rapid switching between imaging modalities and ensures accurate co-registration of images. This level of precision allows for groundbreaking research in cancer ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
OSE’s R&D team and its academic partners have characterized the myeloid checkpoint CLEC-1 (a C-type lectin receptor) as a new therapeutic target in immuno-oncology and identified monoclonal antibody antagonists blocking this novel “Don’t Eat Me” signal. CLEC-1 antagonist monoclonal antibodies have been identified as an innovative cancer immunotherapy that releases the ...
Manufactured by:phasetwo based inAlpharetta, GEORGIA (US) (USA)
The Cryogenic Rack Freezer by phasetwo integrates advanced technology to deliver precise and secure low-temperature storage solutions. Engineered for high capacity use, the freezer incorporates a Low-Level Temperature Alarm system, ensuring continuous monitoring of the internal environment even as products are moved. The unique design allows for lid storage on the handle, enhancing accessibility ...
Manufactured by:Bionix LLC based inMaumee, OHIO (USA)
Created with a focus on ensuring patient comfort, re-positional accuracy and simplicity in use, the Bionix Prone Breast System reduces irradiation to the chest wall, healthy cardiac tissue and lungs. With every Prone Breast System that is purchased, Bionix will donate a portion of the proceeds to breast cancer ...
by:Huabio based inWoburn, MASSACHUSETTS (USA)
ICC staining of PRMT1 in D3 cells (red). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with the primary antibody (ET1704-19, 1/50) for 1 hour at room temperature, washed with PBS. Alexa Fluor®594 Goat anti-Rabbit IgG was used as the secondary ...
by:BICO - The Bio Convergence Company based inBoston, MASSACHUSETTS (USA)
Automated sorting and isolation of single spheroids and organoids. A game-changer in drug screening and other applications where standard 3D models will gradually replace traditional animal models. spheroONE is an innovative single large-particle sorter and dispenser which revolutionizes 3D cellular models handling. Using precision dispensing technology together with advanced image-based sorting ...
Manufactured by:Quanterix Corporation based inBillerica, MASSACHUSETTS (USA)
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex circulating biomarker detection at the earliest stages of disease progression - even at healthy baseline levels. The Quanterix SP-X Imaging and Analysis System is a complete benchtop system that offers true multiplex detection at both acute and baseline levels. For the first time, oncology and ...
Manufactured by:Celemics, Inc. based inSeoul, SOUTH KOREA
Celemics’ Oncorisk Panel is specifically designed to analyze hereditary cancer associated genes. The OncoRisk Panel targets 31 well-known oncogenes, leading to a reduction of totalsequencing cost compared to whole genome sequencing or whole exome sequencing. Additionally, if the gene of interest does not exist on the panel, it can be added separatelythrough our gene add-on service. This ...
Manufactured by:Virasoft Inc. based inSarıyer, TURKEY
In reporting of breast cancer pathology, mitosis detection and counting of mitotic cells are important factors that affect the tumor grade and the treatment of the patient. Mitotic cell counting requires standardization to a fixed field area. The total number of mitoses per 10 HPF is recorded. Normally, the count is performed manually by pathologists, but automating the process could reduce its ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
Expand your research to cover 2M to 130M sequencing reads per run with this scalable platform. The Ion GeneStudio S5 systems are designed to enable a broad range of targeted next-generation sequencing (NGS) applications with speed and scalability. Five Ion S5 chips enable a sequencing throughput range of 2M to 130M reads per ...
Manufactured by:Platypus Technologies, LLC based inMadison, WISCONSIN (USA)
The Oris Cell Migration Assay platform uses a 96-well plate with “stopper” barriers that create a central cell-free Detection Zone for cell migration experiments. Removing the stoppers allows the cells to migrate into the Detection Zone at the center of each ...
Manufactured by:Ansell Ltd. based inBrussels, BELGIUM
The Micro-Touch Nitrafree Nitrile examination gloves are made from a durable and soft nitrile formulation manufactured without chemical accelerators, helping to protect users from Type IV chemical allergies. Provides comfortable and reliable protection while supporting breast cancer ...
Manufactured by:StressMarq Biosciences Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Product Name: c-Met Antibody (pTyr1234). Description: Rabbit Anti-Human c-Met (pTyr1234) Polyclonal. Species Reactivity: Human, Mouse, Rat. Applications: WB. Antibody Dilution: WB (1:250-1:1000); optimal dilutions for assays should be determined by the user. Host Species: Rabbit. Immunogen Species: Human. Immunogen: Synthetic phospho-peptide from human c-Met around the phosphorylation site of ...
Manufactured by:Inovarion based inParis, FRANCE
The latest advances in cancerology have made it possible to dissect the complexity of the signaling pathways leading to cancerous pathologies. New lines of thought have thus been drawn up in terms of therapies and tumor characterization. The mechanisms of oncogenesis, resistance to treatments and the identification of diagnostic biomarkers are major areas of research. Our teams can intervene on a ...